Group 1 - The life and health sector is entering a new stage of "deep integration and rapid development," with cutting-edge technologies like artificial intelligence and brain-computer interfaces expanding the pathways for innovative drug and therapy translation [2][3] - The "5th Guanghua Forum" held at Fudan University focused on themes such as innovative drugs, translational medicine, smart medicine, and brain-computer interfaces, creating a high-end platform for idea exchange and resource connection [2][3] Group 2 - The forum was guided by Fudan University, the Fudan University Alumni Association, and the Macau University of Science and Technology Foundation, and co-hosted by the Guanghua Life and Health Branch of the Fudan University Alumni Association and the Macau Translational Medicine Center [3] - Han Qide, an academician of the Chinese Academy of Sciences, emphasized the importance of practical technology that can solve real-world problems and benefit the public [3][4] Group 3 - Fudan University is shifting its focus from building key disciplines to serving strategic areas, promoting interdisciplinary integration and original innovation in life sciences and medicine [4] - The Guanghua Life and Health Branch has established a network of over 6,000 alumni and 14 council units, fostering collaboration and creating an influential alumni ecosystem in the life and health sector [4][5] Group 4 - The Guanghua Life and Health Branch plans to focus on result transformation by organizing project showcases and facilitating resource connections for early-stage innovation projects [5] - The branch aims to assist alumni enterprises in overcoming challenges and expanding collaborative innovation channels, contributing to the development of the life and health sector [5][6] Group 5 - A new research institute will be established through a cooperation agreement between the Macau Translational Medicine Center and Fudan University’s affiliated Pudong Hospital, focusing on micro-nano sensing technology and organ-on-chip research [6] - The research institute aims to develop platforms for drug screening, disease modeling, and precision medicine diagnostics, while also cultivating high-end talent with international perspectives [6]

Core Viewpoint - A recent study from Italy highlights the significant role of the vagus nerve in maintaining heart function, demonstrating that repairing severed connections can prevent premature aging of heart muscle cells and sustain cardiac pumping performance [1]. Group 1: Research Findings - The vagus nerve, a mixed nerve extending from the brain to various organs, influences functions such as circulation, respiration, and digestion [1]. - The study conducted by the Scuola Superiore Sant'Anna and other institutions found that repairing vagus nerve connections during thoracic surgery can prevent heart function impairment [1]. - Researchers severed the right vagus nerve in male miniature pigs and implanted an artificial nerve conduit, which promoted nerve growth and improved activity levels [1]. Group 2: Experimental Results - Pigs that received conduit treatment showed repaired right vagus nerve connections and maintained better cardiac mechanical performance compared to untreated pigs [1]. - Even a partial restoration of 20% of the nerve connections was sufficient to inhibit oxidative stress-induced premature aging of heart muscle cells [1]. - The study indicates that severing vagus nerve connections accelerates heart aging, but partial repair can counteract cardiac remodeling mechanisms [1]. Group 3: Implications of Cardiac Remodeling - Cardiac remodeling refers to changes in the structure and function of the heart in response to damage or prolonged stress, which can temporarily maintain pumping ability but may lead to long-term deterioration and heart failure [1].

Core Viewpoint - The article discusses a groundbreaking study that reveals the changes in the adipose tissue microenvironment during obesity and weight loss, providing insights for clinical interventions and metabolic health management [18]. Group 1: Overview of Adipose Tissue Remodeling - The study constructed a single-cell atlas of adipose tissue from 70 subjects, analyzing 171,247 cells, including 25 severely obese individuals (pre- and post-surgery) and 24 healthy weight individuals, focusing on subcutaneous abdominal fat [8]. - In obese individuals, there is an abnormal accumulation of immune cells (macrophages, lymphocytes) and a decrease in mature adipocytes, indicating cell apoptosis or insufficient new cell formation; these abnormalities significantly improve after weight loss [8]. Group 2: Abnormal Activation of Macrophages - The proportion of macrophages in adipose tissue increases from 14% to 31% during obesity, particularly lipid-associated macrophages (LAMs), which show enhanced expression of lipid metabolism and inflammation markers [10]. - Weight loss reduces the macrophage proportion to 18% and decreases the expression of inflammation-related genes, although some metabolic activation may not fully reverse, suggesting an epigenetic "memory" [10]. Group 3: Newborn Adipocytes and Metabolic Adaptation - Eight types of mature adipocytes were identified, with "stress-type" (AD3) and "fibrotic-type" (AD6) significantly increasing in obesity, while "lipid-synthesis-type" (AD5) decreases; weight loss effectively reduces the stress-type cells and restores the lipid-synthesis-type [12]. - Obese adipocytes show insufficient fatty acid and branched-chain amino acid (BCAA) breakdown, while weight loss enhances adipocyte metabolic flux, promoting lipid cycling and BCAA breakdown, which improves insulin sensitivity [12]. Group 4: Reversal of Multi-Cellular "Stress" State - Adipose precursor cells (APCs) identify multiple subtypes, with the "stress-type" (APC3) increasing in obesity; weight loss reduces the proportion of stress-type and fibrotic APCs and downregulates hypoxia and anti-adipogenic signals [14]. - In vascular cells, capillary endothelial and wall cells exhibit "stress-type" subpopulations, expressing genes related to vascular disease and fibrosis, which are effectively reduced after weight loss [14]. Group 5: Weight Loss Delays Cellular Aging - Weight loss downregulates multiple cellular aging markers (e.g., CDKN1A/p21), reducing the aging characteristics of adipose, precursor, and vascular cells [16]. - Transcriptional regulation shows that stress and aging cells share a common network that drives cell cycle arrest and inflammation signaling, which can be effectively shut down or alleviated by weight loss [16].

Core Viewpoint - The article highlights the establishment and mission of the Hangzhou Institute of Medicine, which aims to advance precision medicine through innovative research and collaboration in translational medicine [4]. Group 1: Institute Overview - The Hangzhou Institute of Medicine (HIMCAS) was founded in 2019 as a forward-looking medical research institution under the Chinese Academy of Sciences [4]. - HIMCAS focuses on connecting molecular discoveries with clinical solutions to accelerate the development of next-generation therapies addressing global health challenges [4]. Group 2: Recruitment Opportunities - HIMCAS is actively recruiting outstanding scientists globally, offering positions such as Senior PI, Junior PI, Postdoctoral Fellow, and Core Facility Specialists [6][7]. - Senior PI candidates should currently hold associate professor positions or higher at renowned institutions, demonstrating leadership and impactful research [6]. - Junior PI positions are aimed at young scientists with significant research achievements, providing a platform for independent research development [7]. Group 3: Advantages of HIMCAS - HIMCAS benefits from clinical integration with its affiliated hospital, Zhejiang Cancer Hospital, facilitating access to extensive clinical data and patient cohorts [8]. - The institute boasts a distinguished talent ecosystem, with over one-third of core researchers receiving national awards and more than 70% having international research experience [8]. - HIMCAS operates competitive core facilities across five key platforms, enabling seamless interdisciplinary research from molecular discovery to translational application [8][9]. Group 4: Strategic Location and Support - HIMCAS is strategically located in the Qiantang Biomedical Town, surrounded by over 1,000 biotechnology companies, enhancing its research and commercialization capabilities [9]. - The institute offers competitive salaries, substantial startup funding, and comprehensive support for establishing impactful research projects [9]. - Living in Hangzhou provides researchers with a vibrant and livable environment, known for its cultural heritage and innovation ecosystem [9].

Core Insights - Artificial intelligence is becoming a key force driving transformation in the healthcare sector, focusing on precision in disease diagnosis, personalized treatment plans, efficient drug development, and intelligent health management [1][4]. Group 1: AI in Healthcare - AI is reconstructing the healthcare service paradigm by breaking down geographical barriers in medical resources, enhancing grassroots diagnosis, and ensuring precise health knowledge dissemination [4]. - Experts emphasize the importance of integrating AI in early identification and personalized intervention for neurological diseases, showcasing significant advancements in stroke prevention and treatment [4][5]. - The integration of AI with traditional Chinese medicine is highlighted as a means to innovate while preserving the essence of traditional practices [8]. Group 2: Medical Talent Development - High-quality discipline construction in public hospitals is essential for cultivating exceptional medical talent and improving healthcare service quality [6]. - A differentiated evaluation system is proposed to adapt to the "Healthy China" strategy, focusing on both innovative and clinical medical talents [7]. - Emphasis is placed on interdisciplinary collaboration and practical-oriented training to enhance the capabilities of medical professionals [7]. Group 3: Health Management Innovations - The "People's Good Doctor Family Health Care Service" project aims to create an intelligent, inclusive, and reliable health protection system for the public, utilizing AI technology [20]. - The launch of the "People's Good Doctor Corpus" aims to provide reliable information and verification services for healthcare professionals and the public [15]. - The establishment of the "People's Good Doctor·Zhong Nanshan Science Popularization Joint Laboratory" is intended to build a robust health science communication system [12]. Group 4: Future Directions - The conference highlighted the need for continuous optimization of medical talent training systems and the integration of digital technologies in healthcare [5][6]. - Discussions on the coexistence of medical humanities and AI suggest that AI can enhance the quality of medical services while promoting humanistic care [25].

Core Insights - A groundbreaking meta-analysis published in *The Lancet Diabetes & Endocrinology* reveals a strong dose-response relationship between weight loss and diabetes remission in overweight or obese patients with type 2 diabetes [6][9] Summary by Sections Weight Loss and Diabetes Remission - The study found that weight loss is crucial for controlling type 2 diabetes and reducing the risk of related complications, providing clear treatment goals and expected outcomes for clinicians and patients [9] - A systematic review of randomized controlled trials identified 22 high-quality studies, focusing on complete and partial remission metrics [7] Remission Rates Based on Weight Loss - Dramatic differences in complete remission rates were observed based on weight loss: only 0.7% of patients losing less than 10% of their body weight achieved complete remission, while nearly half (49.6%) of those losing 20%-29% and 79.1% of those losing over 30% achieved complete remission [7][8] - Partial remission rates also showed a clear ascending trend: 5.4% for less than 10% weight loss, 48.4% for 10%-19%, 69.3% for 20%-29%, and 89.5% for over 30% [7] Statistical Findings - Each 1% reduction in body weight increases the probability of complete remission by 2.17% and partial remission by 2.74% [8] - The study did not find significant associations between remission outcomes and factors such as age, gender, race, duration of diabetes, baseline body mass index, hemoglobin A1c levels, insulin use, or weight loss intervention methods [8]

Core Viewpoint - Obesity is a significant risk factor for cancer, being the second leading preventable cause after smoking, with over 13 types of cancer closely linked to obesity [6]. Group 1: Obesity and Cancer - Obesity accelerates the occurrence and progression of cancer, yet obese patients often show a "protective effect" during immunotherapy, responding better to treatments and having improved survival rates [7]. - A recent study from Vanderbilt University published in *Nature* reveals that inflammatory cytokines induced by obesity stimulate the expression of PD-1 on tumor-associated macrophages (TAM), weakening the immune surveillance against tumors while simultaneously enhancing the efficacy of anti-PD-1 immunotherapy [8][12]. Group 2: Research Findings - In experiments with mice, those on a high-fat diet (HFD) exhibited significant weight gain and metabolic abnormalities, leading to accelerated tumor growth when injected with cancer cells. However, only the HFD group showed notable anti-tumor effects when treated with anti-PD-1 antibodies [11]. - Analysis of immune cells from HFD mice indicated a decrease in specific CD8+ T cells and an increase in macrophages, with significant changes in TAM, including elevated PD-1 expression and altered metabolic states [14][16]. Group 3: Mechanisms and Implications - The study highlights that obesity-related inflammatory factors like INF-γ and TNF-α upregulate PD-1 expression in macrophages through signaling pathways, which in turn suppresses TAM functionality and reduces T cell activation [17]. - This mechanism suggests that anti-PD-1 inhibitors could effectively counteract the suppressive effects of obesity on TAM, thereby enhancing T cell anti-tumor activity in high BMI populations [18]. Group 4: Future Research Directions - Further investigation is needed to explore the roles of other innate immune cells and different dietary structures in the context of tumor immunity and the effects of obesity [18].

Group 1 - The core viewpoint emphasizes the importance of integrating artificial intelligence (AI) tools in the medical field to advance medical science [1] - The expert, Zhong Nanshan, encourages continuous learning of AI among medical professionals, sharing his own experience of struggling initially but persisting in learning [1] - There is a call for collaboration among professionals in virus research, including clinical, laboratory, and basic research personnel, to enhance the application of AI in medicine [1]

Core Viewpoint - The article emphasizes the importance of fat distribution over total fat amount in determining health risks, highlighting a new AI-based research approach that provides more accurate health risk assessments [5][7][10]. Research Highlights - Traditional health risk assessment tools like BMI are inadequate as they do not differentiate between fat and muscle or show fat distribution, leading to varying health risks among individuals with the same BMI [7]. - A study utilizing AI technology analyzed over 33,000 MRI scans from the UK Biobank, revealing that visceral fat around organs and intramuscular fat are closely linked to higher risks of diabetes and cardiovascular diseases, even when considering BMI and waist circumference [7][10]. - The study found that low muscle mass in men increases the risk of related health issues, a trend not observed in women, indicating potential gender differences in the impact of fat distribution and muscle quality on health risks [9]. Significance of the Research - The research demonstrates that AI can enhance the precision of health risk assessments by analyzing body scan images, identifying that fat around organs and within muscles poses greater health threats compared to fat in other areas [10]. - The findings suggest that widespread adoption of this AI technology could enable earlier identification of high-risk individuals and facilitate personalized prevention and management strategies for chronic diseases like diabetes and heart disease [10]. - This advancement not only offers a new tool for the medical community but also holds promise for improving public health management through more accurate risk assessments [10].

Core Insights - A new study from Turku University in Finland indicates a correlation between gut microbiome status during pregnancy and postpartum body fat content and weight changes [1][2] - Women with lower gut microbiome diversity during pregnancy have a higher probability of postpartum obesity [1] Group 1: Research Findings - The study involved follow-up data from over 250 pregnant women, revealing multiple associations between gut microbiome during pregnancy and postpartum overweight and obesity, particularly evident one to two years after childbirth [1] - Women who maintained normal weight within a year postpartum had higher levels of certain bacteria, such as the genus of Actinobacteria, while the presence of Ruminococcus and Clostridium was linked to weight status two years postpartum [1] - The gut microbiome "functional profile" inferred from metagenomic data showed predictive capabilities for body mass index and body fat percentage in women one year postpartum [1] Group 2: Broader Context - The global obesity rate continues to rise, affecting an increasing number of women of childbearing age, with estimates suggesting that nearly one in two pregnant women is overweight or obese [2] - Maternal obesity during pregnancy increases health risks for both mothers and fetuses during and after pregnancy [2] - The research findings have been published in the American academic journal "Microbiology (Open)" [2]